MJNA - Medical Marijuana, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
0.0604
+0.0002 (+0.33%)
As of 12:43PM EDT. Market open.
Stock chart is not supported by your current browser
Previous Close0.0602
Open0.0603
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.0600 - 0.0650
52 Week Range0.0600 - 0.1200
Volume7,400,496
Avg. Volume7,714,184
Market Cap218.707M
Beta (3Y Monthly)-1.58
PE Ratio (TTM)N/A
EPS (TTM)-0.0920
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • PR Newswire4 days ago

    Medical Marijuana, Inc. Reports Fourth Quarter and Year-End Financial and Operational Results: Net Revenue Increase 125% Year-Over-Year

    SAN DIEGO , April 18, 2019 /PRNewswire/ --  Medical Marijuana, Inc.  (OTC: MJNA), the first-ever publicly traded cannabis company in the United States , today announced financial results for the quarter ...

  • PR Newswire5 days ago

    Bloomberg News Features Medical Marijuana, Inc. CEO Discussing Growth of CBD Market in Brazil

    SAN DIEGO , April 17, 2019 /PRNewswire/ --  Medical Marijuana, Inc. (OTC: MJNA), the first publicly traded cannabis company in the United States , today announced that it has garnered news coverage in ...

  • Market Exclusive5 days ago

    Cannabis Stock News Daily Roundup April 17

    Medical Marijuana (OTC: MJNA) subsidiary Phyto Animal Health announced the launch of its newest cannabidiol pet product, Skin Vitality. The salve is intended to treat itching, support muscle and skin recovery and provide relief for hot spots, wounds, bug bites, flea dermatitis and rashes. GB Sciences (OTCQB: GBLX), a partner in GB Sciences Louisiana, said that all cultivation […]The post Cannabis Stock News Daily Roundup April 17 appeared first on Market Exclusive.

  • Medical Marijuana, Inc. Subsidiary Phyto Animal Health Adds Skin Vitality to World's Leading CBD Pet Product Line
    PR Newswire6 days ago

    Medical Marijuana, Inc. Subsidiary Phyto Animal Health Adds Skin Vitality to World's Leading CBD Pet Product Line

    SAN DIEGO, April 16, 2019 /PRNewswire/ -- Medical Marijuana, Inc. (MJNA), the first-ever publicly traded cannabis company in the United States, subsidiary Phyto Animal Health today announced the launch of its newest cannabidiol (CBD) pet product, Skin Vitality. Skin Vitality is a salve formulated for use as an itch and hot spot treatment balm. Phyto Animal Health's new Skin Vitality salve is specially formulated for the sensitive skin of dogs, cats and horses to provide them with an all-natural method of relief and recovery," said Phyto Animal Health CEO Ian Quinn.

  • PR Newswire11 days ago

    Medical Marijuana, Inc. Subsidiary Kannaway® Predicts Upcoming "Believe" National Convention to be Largest in Company History

    SAN DIEGO, April 11, 2019 /PRNewswire/ -- Medical Marijuana, Inc. (MJNA), the first-ever publicly traded cannabis company in the United States, subsidiary Kannaway® announced today that is hosting its "Believe" National Convention from April 12-14 in San Diego, CA at the Sheraton San Diego Hotel & Marina. The company predicts that this convention will be the largest U.S. event in the company's history. Attendees will have the opportunity to learn first-hand about Kannaway®'s history and latest developments as well as celebrate Kannaway®'s impressive growth with fellow Brand Ambassadors from around the world.

  • Pot for Pets? Canopy Growth Is on the Bleeding-Edge of Marijuana Stocks
    InvestorPlace12 days ago

    Pot for Pets? Canopy Growth Is on the Bleeding-Edge of Marijuana Stocks

    Marijuana stocks have been all the rage as legalization for medical and personal use has expanded. Leading the way is superstar Canopy Growth (NYSE:CGC). CGC has been riding high as it continues to see rising sales and has racked up some major deals with blue-chip companies such as Constellation Brands (NYSE:STZ).Source: Shutterstock There's a reason why Canopy could be one of the marijuana stocks first real winners on the race to profitability. Part of the reason is that Canopy is forward thinking.Just as it made some of the first moves into cannabis-infused drinks and other products with its STZ partnership, it's doing so with its latest deals. That will have it front and center in the animal and pet health marketplace. Don't laugh. Petcare is a booming and thriving business. Fertile ground for marijuana stocks to profit.InvestorPlace - Stock Market News, Stock Advice & Trading TipsAnd now, Canopy Growth has the chance to be the leading cannabis stock in the sector. A Big Market for the Marijuana StocksIt's no secret that Americans love their pets. A 2012 Harris Interactive survey found that 9 out 10 respondents viewed their companion pets as a member of the family. The survey also found that these respondents were willing to do whatever is necessary to ensure the health of their pet. And in that love and willingness, many Americans tend to spend almost nearly as much money on them as we do our own children.The American Pet Product Association data shows that annual expenditures by consumers for their pets have grown in each of the last 18 years. This includes during the Great Recession. Last year alone, Americans spent a whopping $72.56 billion on their pets. This includes $18.3 billion on veterinary care and $15.5 billion on supplies and over-the-counter medicines. This year, the APPA estimates that number will surge to more than $75 billion. The truth is, American's are very willing to spend on their fur babies.What does this have to do with marijuana stocks?While cats and dogs are very different than people, they do benefit from some of the same treatments for ailments. A lot of feline and canine drugs have been derived from their human counterparts. For example, our vet prescribes half a Benadryl tablet for our dog when his spring allergies start.With that, it stands to reason that dogs and cats may benefit from similar positive health-effects from cannabinoid and hemp-based CBD products. Already, several studies are underway with the both Colorado State University and the University of Pennsylvania School of Veterinary Medicine looking into CBD treatments for pets with osteoarthritis/joint pain and epilepsy. Meanwhile, just as there is a big and growing market for human supplements using CBD, there's massive potential for pet products as well.For the various marijuana stocks, this is a huge untapped market that they certainly can compete in, now that the Farm Bill has passed and hemp-based CBD is legal in many items. For Canopy Growth, the potential seems very big considering its recent moves. Canopy Growth Could Be the Leading Marijuana Stock for PetsCGC is poised to win in the booming pet care market thanks to another smart partnership. Around the end of March, Canopy cut a deal with Sequential Brands Group. The deal with Sequential puts CGC right into the thick of the pet care market as the collaboration focuses on the pair developing new hemp-derived cannabidiol (CBD) products for animals. The deal was sort of swept under the rug as other marijuana stock news was breaking around that time. But in the deal, was a huge coup for Canopy. And that was Martha Stewart.Yes, that Martha Stewart.The homemaker and entertaining queen provides plenty of brand cache for Canopy as she will become a strategic advisor on the firm's pet and hemp-product lines. Stewart has long been a pet advocative and her chow chows have become stars in their own right. With her on board, sales for whatever CGC develops could quickly find a foothold and command some high market share in the CBD pet product sector.One of the chief reasons why Canopy has been crushing other marijuana stocks has been the strength of its celebrity and major corporate partnerships. The firm has been able to get out in front of some major trends -- like CBD-infused drinks -- and has been able to capitalize on that with big deals. Pets and animal health will be no different. By adding Martha to the mix, it legitimizes its future products and gives it a major edge on supermarket shelves. That's something other pet-focused marijuana stocks like Medical Marijuana, Inc. (NASDAQ:MJNA) or CannTrust Holdings (NYSE:CTST) may not be able to match.All in all, it's just another reason why CGC is pulling away from the pack. Forget the Other Marijuana StocksThe reality is, the pot sector is quickly turning into a one or two horse race with Canopy leading the way. The firm continues to make major transformative deals to get itself out in front of major trends. It's under the rug deal with Sequential Brans puts it right front and center in a huge and growing market. The branding with Martha Stewart will only enhance that further. For investors, it's just another example of why CGC is the cannabis stock to own.As of this writing, Aaron Levitt did not hold a position in any of the aforementioned securities. More From InvestorPlace * 2 Toxic Pot Stocks You Should Avoid * 9 Best Dividend Stocks to Buy for Every Investor * 7 Catalysts That Will Send Marijuana Stocks Soaring in 2019 * 8 Risky Stocks to Watch as Earnings Season Kicks Off Compare Brokers The post Pot for Pets? Canopy Growth Is on the Bleeding-Edge of Marijuana Stocks appeared first on InvestorPlace.

  • PR Newswire12 days ago

    Medical Marijuana, Inc. Investment Company AXIM® Biotechnologies Enters Services Agreement with CRO to Begin Clinical Studies on Dronabinol and CBD Chewing Gums

    SAN DIEGO , April 10, 2019 /PRNewswire/ --  Medical Marijuana, Inc. (OTC: MJNA), the first-ever publicly traded cannabis company in the United States , announced that its investment company AXIM® Biotechnologies ...

  • PR Newswire13 days ago

    Medical Marijuana, Inc. Subsidiary HempMeds® Secures 100 New Retail Locations in Q1 2019 and Announces Distribution Partnership with Largest Hawaiian CBD Retailer

    SAN DIEGO, April 9, 2019 /PRNewswire/ -- Medical Marijuana, Inc. (MJNA), the first-ever publicly traded cannabis company in the United States, subsidiary HempMeds® announced today that the company has secured 100 new retail locations in Q1 2019, significantly outpacing its growth forecast for that time period. As a part of this growth, Vim N' Vigor, the largest cannabidiol (CBD) retailer in Hawaii, has partnered with the company to sell its oral, topical, and edible CBD products. "I am proud of the hard work of my team this past month and our ability to partner with family-owned retailers like Vim N' Vigor that are dedicated to listening to its customers and providing them with the high-quality CBD products they need," said HempMeds® President Todd Morrow.

  • PR Newswire17 days ago

    U.S. Paralympic Athlete Samantha Tucker Joins Medical Marijuana, Inc. Subsidiary Kannaway® Sports Team

    SAN DIEGO, April 5, 2019 /PRNewswire/ -- Medical Marijuana, Inc. (MJNA), the first-ever publicly traded cannabis company in the United States, announced today that U.S. Paralympic athlete Samantha Tucker has joined its subsidiary Kannaway® as a company spokesperson to help spread awareness on the benefits of hemp cannabidiol (CBD) for athletes and active consumers. "Samantha is exactly the type of representation that we need on our Kannaway Sports Team," said Kannaway CEO Blake Schroeder.

  • PR Newswire18 days ago

    Medical Marijuana, Inc. and Subsidiaries Kannaway®, HempMeds® Brasil and Phyto Animal Health Announce March 2019 as the Largest Revenue Month in Company History

    SAN DIEGO , April 4, 2019 /PRNewswire/ --  Medical Marijuana, Inc.  (OTC: MJNA), the first-ever publicly traded cannabis company in the United States , today announced that the company had its the largest-ever ...

  • PR Newswire21 days ago

    Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Sponsors International Autistic Week in Ribeirao Preto, Brazil

    SAN DIEGO, April 1, 2019 /PRNewswire/ -- Medical Marijuana, Inc. (MJNA), the first publicly traded cannabis company in the United States, today announced that its subsidiary HempMeds® Brasil will be sponsoring TEAbraco 2019 International Autism Week from April 1 to April 7 at the Iguatemi Mall in Ribeirão Preto, Brazil. "As a company, we see events like this one as prime opportunities to educate the people of Brazil about the history of medical cannabis, the difference between hemp and marijuana and our cannabidiol (CBD) products and their potential benefits," said HempMeds® Vice President Caroline Heinz. "In Brazil, CBD is legal to be imported and is even subsidized by the Brazilian Government for several indications including autism.

  • Market Exclusive25 days ago

    AXIM Biotechnologies Gets U.S. Patent for CBD Cream to Treat Atopic Dermatitis

    Medical Marijuana (OTC: MJNA) reported that its portfolio company AXIM Biotechnologies (OTCQB: AXIM) has been granted a patent by the United States Patent and Trademark Office (USPTO) for a method to treat atopic dermatitis using cannabinoids. The USPTO has issued a notice of allowance for the patent to the company for a method to treat […]The post AXIM Biotechnologies Gets U.S. Patent for CBD Cream to Treat Atopic Dermatitis appeared first on Market Exclusive.

  • PR Newswire25 days ago

    NFL Veteran Mark Walczak Joins Medical Marijuana, Inc. Subsidiary Kannaway as Spokesperson

    SAN DIEGO, March 28, 2019 /PRNewswire/ -- Medical Marijuana, Inc. (MJNA), the first-ever publicly traded cannabis company in the United States, announced today that former NFL Tight End and Snapper Mark Walczak has joined its subsidiary Kannaway® as a company spokesperson to help spread awareness on the benefits of hemp cannabidiol (CBD) for athletes and active consumers. "Our athlete partnerships prove that CBD isn't just something that's trendy right now, it's something that is actually helping people live their best lives every day," said Kannaway® CEO Blake Schroeder.

  • PR Newswire26 days ago

    Medical Marijuana, Inc. Portfolio Company AXIM® Biotechnologies Receives New U.S. Patent Issuance for Topical Cream Containing Cannabinoids

    SAN DIEGO , March 27, 2019 /PRNewswire/ --  Medical Marijuana, Inc. (OTC: MJNA), the first-ever publicly traded cannabis company in the United States , announced that its portfolio company AXIM® Biotechnologies ...

  • PR Newswire27 days ago

    Medical Marijuana, Inc. Subsidiary Phyto Animal Health Announces Participation at NoCo Hemp Expo in Denver

    SAN DIEGO , March 26, 2019 /PRNewswire/ --  Medical Marijuana, Inc.  (OTC: MJNA), the first-ever publicly traded cannabis company in the United States , subsidiary Phyto Animal Health today announced that ...

  • PR Newswirelast month

    Medical Marijuana, Inc. Celebrates Company's 10-Year Anniversary

    SAN DIEGO, March 22, 2019 /PRNewswire/ -- Medical Marijuana, Inc. (MJNA), the first-ever publicly traded cannabis company in the United States, announced today that the company is celebrating its 10-year anniversary tomorrow, March 23, 2019. "It's been an incredible experience to be a part of the cannabis and hemp cannabidiol (CBD) industries over the past decade," said Medical Marijuana, Inc. CEO Dr. Titus. Reports released last year by analysts Cowen & Co. estimate that the cannabis industry could generate $75 billion in sales by 2030.

  • PR Newswirelast month

    Medical Marijuana, Inc. Subsidiary Kannaway® Adds Cincinnati Bengals Super Bowl Legend Kenneth Christopher "Skip" McClendon as Spokesperson

    SAN DIEGO, March 20, 2019 /PRNewswire/ -- Medical Marijuana, Inc. (MJNA), the first-ever publicly traded cannabis company in the United States, announced today that its subsidiary Kannaway® is pleased to welcome Kenneth Christopher "Skip" McClendon as a company spokesperson to help spread awareness on the benefits of hemp cannabidiol (CBD) for athletes and active consumers. "For many, CBD is the last solution to their problems when it should actually be their first," said Kannaway® CEO Blake Schroeder. McClendon played as a Defensive End in the NFL from 1987 to 1993.

  • PR Newswirelast month

    Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Hosts Medical Cannabis Event in Bahia

    SAN DIEGO , March 18, 2019 /PRNewswire/ --  Medical Marijuana, Inc.  (OTC: MJNA), the first publicly traded cannabis company in the United States , today announced that its subsidiary HempMeds® Brasil ...

  • PR Newswirelast month

    San Diego Union-Tribune Features Op-Ed by Medical Marijuana, Inc. CEO Discussing Hemp's Future in the U.S. and San Diego

    SAN DIEGO, March 14, 2019 /PRNewswire/ -- Medical Marijuana, Inc. (MJNA), the first publicly traded cannabis company in the United States, today announced that an op-ed article written by the company's CEO Dr. Stuart Titus was published in the prestigious regional news publication, The San Diego Union-Tribune. "It's an honor to be featured in this publication and help consumers understand that hemp and CBD are not just a fad, they're here to stay," said Titus. In addition to explaining how international regulatory bodies, such as the World Health Organization, have stated that CBD is "is not harmful, has health benefits, and does not have abuse potential," the article outlines an analysis by The Brightfield Group that positions the market for hemp-derived CBD products, which was about $591 million in 2018, to grow to $22 billion by 2022.

  • PR Newswirelast month

    Kansas City Chiefs Hall-of-Famer John Alt Joins Medical Marijuana, Inc. Subsidiary Kannaway® Sports Team

    SAN DIEGO, March 13, 2019 /PRNewswire/ -- Medical Marijuana, Inc. (MJNA), the first-ever publicly traded cannabis company in the United States, announced today that former Kansas City Chiefs Offensive Lineman John Alt has joined as their newest spokesperson for its subsidiary Kannaway® to help spread awareness on the benefits of hemp cannabidiol (CBD) for athletes and active consumers. "We are excited that John as seen great results on our Revive, Kannaway Gold and Kannaway Premium Full-Spectrum products," said Kannaway® CEO Blake Schroeder.

  • Medical Marijuana, Inc. Subsidiary HempMeds® Celebrates International Women's Day with New CBD Personal Care Line
    PR Newswirelast month

    Medical Marijuana, Inc. Subsidiary HempMeds® Celebrates International Women's Day with New CBD Personal Care Line

    SAN DIEGO, March 8, 2019 /PRNewswire/ -- Medical Marijuana, Inc. (MJNA), the first-ever publicly traded cannabis company in the United States, announced today that its subsidiary HempMeds® has launched its newest cannabidiol (CBD) Personal Care Line in celebration of International Women's Day. According to a new report by Eaze, an online marketplace and technology platform for legal cannabis, the number of women buying cannabis products almost doubled in 2018, increasing by 92 percent. Women now make up 38 percent of all cannabis consumers.

  • PR Newswire2 months ago

    Medical Marijuana, Inc. Subsidiary Kannaway® Sports Team Welcomes Former Miami Dolphins Linebacker Bruce Bannon

    SAN DIEGO, March 6, 2019 /PRNewswire/ -- Medical Marijuana, Inc. (MJNA), the first-ever publicly traded cannabis company in the United States, announced today that they have welcomed former Miami Dolphins Linebacker Bruce Bannon as their newest spokesperson for its subsidiary Kannaway® to help spread awareness on the benefits of hemp cannabidiol (CBD) for athletes and active consumers. "We're thrilled that Bruce is taking our Pure Gold and Premium Full Spectrum CBD products and we hope that he continues to find success using them," said Kannaway® CEO Blake Schroeder.

  • PR Newswire2 months ago

    Medical Marijuana, Inc. Subsidiaries HempMeds® and Phyto Animal Health Announce Participation at Natural Products Expo West

    SAN DIEGO, March 4, 2019 /PRNewswire/ -- Medical Marijuana, Inc. (MJNA), the first-ever publicly traded cannabis company in the United States, announced today that its subsidiaries HempMeds® and Phyto Animal Health will be attending and exhibiting at Natural Products Expo West at the Anaheim Convention Center in Anaheim, CA on March 6-8, 2019. There, HempMeds® will be revealing its newest cannabidiol (CBD) product line. "Our attendance at this event is just one example of how HempMeds plans to reach a broader audience of business professionals and consumers this year," said HempMeds® President Todd Morrow.

  • PR Newswire2 months ago

    Medical Marijuana, Inc. Subsidiaries Kannaway®, HempMeds® and Dixie Botanicals Receive U.S. Hemp Authority Certification Seal

    SAN DIEGO, March 1, 2019 /PRNewswire/ -- Medical Marijuana, Inc. (MJNA), the first-ever publicly traded cannabis company in the United States, announced today that its subsidiaries Kannaway®, HempMeds® and Dixie Botanicals all received Certification Seals from the U.S. Hemp Authority. To receive this seal, companies must have met several stringent industry standards laid out for quality and safety. The certification is intended to educate hemp farmers and producers about Food and Drug Administration Current Good Manufacturing Practices (cGMP) and Good Agricultural Practices (GAP) to guarantee that consistent quality is achieved.

  • PR Newswire2 months ago

    NFL Hall of Famer Eric Dickerson To Speak at Medical Marijuana, Inc. Subsidiary Kannaway® Believe National Convention

    SAN DIEGO, Feb. 27, 2019 /PRNewswire/ -- Medical Marijuana, Inc. (MJNA), the first-ever publicly traded cannabis company in the United States, announced today that NFL Hall of Famer and former Rams running back Eric Dickerson will be giving a keynote speech at the Believe National Convention in San Diego on April 14, 2019. "This event will be one of our largest and most exciting events yet," said Kannaway CEO Blake Schroeder.